Industry Research Reports
Home > Reports > Medical Devices & Consumables > Global Lung Tumor Ablation Market Research Report 2026
Global Lung Tumor Ablation Market Research Report 2026
Industry: Medical Devices & Consumables
Published Date: 2026-04-17
Pages: 117 Pages
Report ld: 6474322
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Lung Tumor Ablation Market Size(US$)
CAGR 2026-2032
9.3%
Market Size,2032
USD 4,480
Million
Market Snapshot
Market Size in 2026 (Value)
US$ 2,627 million
Market Forecast in 2032(Value)
US$ 4,480 million
CAGR
9.3%
Years Considered
2021-2032
Base Year
2026
Forecast Period
2026-2032
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Lung Tumor Ablation market was valued at US$ 2425 million in 2025 and is anticipated to reach US$ 4480 million by 2032, at a CAGR of 9.3% from 2026 to 2032.
Lung tumor ablation is a minimally-invasive image-guided procedure (MIIP) to destroy the cancer without having to cut it out. Ablation can be an effective treatment option for patients who wish to avoid surgery or for whom surgery is not an option.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report delivers a comprehensive overview of the global Lung Tumor Ablation market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Lung Tumor Ablation. The Lung Tumor Ablation market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Lung Tumor Ablation market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Lung Tumor Ablation manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
By Company
- Medtronic
- Olympus
- LungCare
- Broncus
- Intuitive Surgica
- Auris Health
- Angiodynamics
- Boston Scientific
- Smith and Nephew
- VISON Medical
- Nanjing MICRO-TECH
- TIPC
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Radiofrequency Ablation (RFA)
- Microwave Ablation (MWA)
- Cold Ablation
- Others
Segment by Application
- Hospitals
- Ambulatory Surgical Centers
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Lung Tumor Ablation companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Lung Tumor Ablation Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Radiofrequency Ablation (RFA)
1.2.3 Microwave Ablation (MWA)
1.2.4 Cold Ablation
1.2.5 Others
1.3 Market by Application
1.3.1 Global Lung Tumor Ablation Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Lung Tumor Ablation Market Perspective (2021–2032)
2.2 Global Lung Tumor Ablation Growth Trends by Region
2.2.1 Global Lung Tumor Ablation Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Lung Tumor Ablation Historic Market Size by Region (2021–2026)
2.2.3 Lung Tumor Ablation Forecasted Market Size by Region (2027–2032)
2.3 Lung Tumor Ablation Market Dynamics
2.3.1 Lung Tumor Ablation Industry Trends
2.3.2 Lung Tumor Ablation Market Drivers
2.3.3 Lung Tumor Ablation Market Challenges
2.3.4 Lung Tumor Ablation Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Lung Tumor Ablation Players by Revenue
3.1.1 Global Top Lung Tumor Ablation Players by Revenue (2021–2026)
3.1.2 Global Lung Tumor Ablation Revenue Market Share by Players (2021–2026)
3.2 Global Top Lung Tumor Ablation Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Lung Tumor Ablation Revenue
3.4 Global Lung Tumor Ablation Market Concentration Ratio
3.4.1 Global Lung Tumor Ablation Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Lung Tumor Ablation Revenue in 2025
3.5 Global Key Players of Lung Tumor Ablation Head Offices and Areas Served
3.6 Global Key Players of Lung Tumor Ablation, Products and Applications
3.7 Global Key Players of Lung Tumor Ablation, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Lung Tumor Ablation Breakdown Data by Type
4.1 Global Lung Tumor Ablation Historic Market Size by Type (2021–2026)
4.2 Global Lung Tumor Ablation Forecasted Market Size by Type (2027–2032)
5 Lung Tumor Ablation Breakdown Data by Application
5.1 Global Lung Tumor Ablation Historic Market Size by Application (2021–2026)
5.2 Global Lung Tumor Ablation Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Lung Tumor Ablation Market Size (2021–2032)
6.2 North America Lung Tumor Ablation Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Lung Tumor Ablation Market Size by Country (2021–2026)
6.4 North America Lung Tumor Ablation Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Lung Tumor Ablation Market Size (2021–2032)
7.2 Europe Lung Tumor Ablation Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Lung Tumor Ablation Market Size by Country (2021–2026)
7.4 Europe Lung Tumor Ablation Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Lung Tumor Ablation Market Size (2021–2032)
8.2 Asia-Pacific Lung Tumor Ablation Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Lung Tumor Ablation Market Size by Region (2021–2026)
8.4 Asia-Pacific Lung Tumor Ablation Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Lung Tumor Ablation Market Size (2021–2032)
9.2 Latin America Lung Tumor Ablation Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Lung Tumor Ablation Market Size by Country (2021–2026)
9.4 Latin America Lung Tumor Ablation Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Lung Tumor Ablation Market Size (2021–2032)
10.2 Middle East & Africa Lung Tumor Ablation Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Lung Tumor Ablation Market Size by Country (2021–2026)
10.4 Middle East & Africa Lung Tumor Ablation Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Medtronic
11.1.1 Medtronic Company Details
11.1.2 Medtronic Business Overview
11.1.3 Medtronic Lung Tumor Ablation Introduction
11.1.4 Medtronic Revenue in Lung Tumor Ablation Business (2021–2026)
11.1.5 Medtronic Recent Development
11.2 Olympus
11.2.1 Olympus Company Details
11.2.2 Olympus Business Overview
11.2.3 Olympus Lung Tumor Ablation Introduction
11.2.4 Olympus Revenue in Lung Tumor Ablation Business (2021–2026)
11.2.5 Olympus Recent Development
11.3 LungCare
11.3.1 LungCare Company Details
11.3.2 LungCare Business Overview
11.3.3 LungCare Lung Tumor Ablation Introduction
11.3.4 LungCare Revenue in Lung Tumor Ablation Business (2021–2026)
11.3.5 LungCare Recent Development
11.4 Broncus
11.4.1 Broncus Company Details
11.4.2 Broncus Business Overview
11.4.3 Broncus Lung Tumor Ablation Introduction
11.4.4 Broncus Revenue in Lung Tumor Ablation Business (2021–2026)
11.4.5 Broncus Recent Development
11.5 Intuitive Surgica
11.5.1 Intuitive Surgica Company Details
11.5.2 Intuitive Surgica Business Overview
11.5.3 Intuitive Surgica Lung Tumor Ablation Introduction
11.5.4 Intuitive Surgica Revenue in Lung Tumor Ablation Business (2021–2026)
11.5.5 Intuitive Surgica Recent Development
11.6 Auris Health
11.6.1 Auris Health Company Details
11.6.2 Auris Health Business Overview
11.6.3 Auris Health Lung Tumor Ablation Introduction
11.6.4 Auris Health Revenue in Lung Tumor Ablation Business (2021–2026)
11.6.5 Auris Health Recent Development
11.7 Angiodynamics
11.7.1 Angiodynamics Company Details
11.7.2 Angiodynamics Business Overview
11.7.3 Angiodynamics Lung Tumor Ablation Introduction
11.7.4 Angiodynamics Revenue in Lung Tumor Ablation Business (2021–2026)
11.7.5 Angiodynamics Recent Development
11.8 Boston Scientific
11.8.1 Boston Scientific Company Details
11.8.2 Boston Scientific Business Overview
11.8.3 Boston Scientific Lung Tumor Ablation Introduction
11.8.4 Boston Scientific Revenue in Lung Tumor Ablation Business (2021–2026)
11.8.5 Boston Scientific Recent Development
11.9 Smith and Nephew
11.9.1 Smith and Nephew Company Details
11.9.2 Smith and Nephew Business Overview
11.9.3 Smith and Nephew Lung Tumor Ablation Introduction
11.9.4 Smith and Nephew Revenue in Lung Tumor Ablation Business (2021–2026)
11.9.5 Smith and Nephew Recent Development
11.10 VISON Medical
11.10.1 VISON Medical Company Details
11.10.2 VISON Medical Business Overview
11.10.3 VISON Medical Lung Tumor Ablation Introduction
11.10.4 VISON Medical Revenue in Lung Tumor Ablation Business (2021–2026)
11.10.5 VISON Medical Recent Development
11.11 Nanjing MICRO-TECH
11.11.1 Nanjing MICRO-TECH Company Details
11.11.2 Nanjing MICRO-TECH Business Overview
11.11.3 Nanjing MICRO-TECH Lung Tumor Ablation Introduction
11.11.4 Nanjing MICRO-TECH Revenue in Lung Tumor Ablation Business (2021–2026)
11.11.5 Nanjing MICRO-TECH Recent Development
11.12 TIPC
11.12.1 TIPC Company Details
11.12.2 TIPC Business Overview
11.12.3 TIPC Lung Tumor Ablation Introduction
11.12.4 TIPC Revenue in Lung Tumor Ablation Business (2021–2026)
11.12.5 TIPC Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Lung Tumor Ablation Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Radiofrequency Ablation (RFA)
Table 3. Key Players of Microwave Ablation (MWA)
Table 4. Key Players of Cold Ablation
Table 5. Key Players of Others
Table 6. Global Lung Tumor Ablation Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 7. Global Lung Tumor Ablation Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 8. Global Lung Tumor Ablation Market Size by Region (US$ Million), 2021–2026
Table 9. Global Lung Tumor Ablation Market Share by Region (2021–2026)
Table 10. Global Lung Tumor Ablation Forecasted Market Size by Region (US$ Million), 2027–2032
Table 11. Global Lung Tumor Ablation Market Share by Region (2027–2032)
Table 12. Lung Tumor Ablation Market Trends
Table 13. Lung Tumor Ablation Market Drivers
Table 14. Lung Tumor Ablation Market Challenges
Table 15. Lung Tumor Ablation Market Restraints
Table 16. Global Lung Tumor Ablation Revenue by Players (US$ Million), 2021–2026
Table 17. Global Lung Tumor Ablation Market Share by Players (2021–2026)
Table 18. Global Top Lung Tumor Ablation Players by Tier (Tier 1, Tier 2, and Tier 3), based on Lung Tumor Ablation Revenue, 2025
Table 19. Ranking of Global Top Lung Tumor Ablation Companies by Revenue (US$ Million) in 2025
Table 20. Global 5 Largest Players Market Share by Lung Tumor Ablation Revenue (CR5 and HHI), 2021–2026
Table 21. Global Key Players of Lung Tumor Ablation, Headquarters and Area Served
Table 22. Global Key Players of Lung Tumor Ablation, Products and Applications
Table 23. Global Key Players of Lung Tumor Ablation, Date of General Availability (GA)
Table 24. Mergers and Acquisitions, Expansion Plans
Table 25. Global Lung Tumor Ablation Market Size by Type (US$ Million), 2021–2026
Table 26. Global Lung Tumor Ablation Revenue Market Share by Type (2021–2026)
Table 27. Global Lung Tumor Ablation Forecasted Market Size by Type (US$ Million), 2027–2032
Table 28. Global Lung Tumor Ablation Revenue Market Share by Type (2027–2032)
Table 29. Global Lung Tumor Ablation Market Size by Application (US$ Million), 2021–2026
Table 30. Global Lung Tumor Ablation Revenue Market Share by Application (2021–2026)
Table 31. Global Lung Tumor Ablation Forecasted Market Size by Application (US$ Million), 2027–2032
Table 32. Global Lung Tumor Ablation Revenue Market Share by Application (2027–2032)
Table 33. North America Lung Tumor Ablation Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 34. North America Lung Tumor Ablation Market Size by Country (US$ Million), 2021–2026
Table 35. North America Lung Tumor Ablation Market Size by Country (US$ Million), 2027–2032
Table 36. Europe Lung Tumor Ablation Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 37. Europe Lung Tumor Ablation Market Size by Country (US$ Million), 2021–2026
Table 38. Europe Lung Tumor Ablation Market Size by Country (US$ Million), 2027–2032
Table 39. Asia-Pacific Lung Tumor Ablation Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 40. Asia-Pacific Lung Tumor Ablation Market Size by Region (US$ Million), 2021–2026
Table 41. Asia-Pacific Lung Tumor Ablation Market Size by Region (US$ Million), 2027–2032
Table 42. Latin America Lung Tumor Ablation Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 43. Latin America Lung Tumor Ablation Market Size by Country (US$ Million), 2021–2026
Table 44. Latin America Lung Tumor Ablation Market Size by Country (US$ Million), 2027–2032
Table 45. Middle East & Africa Lung Tumor Ablation Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 46. Middle East & Africa Lung Tumor Ablation Market Size by Country (US$ Million), 2021–2026
Table 47. Middle East & Africa Lung Tumor Ablation Market Size by Country (US$ Million), 2027–2032
Table 48. Medtronic Company Details
Table 49. Medtronic Business Overview
Table 50. Medtronic Lung Tumor Ablation Product
Table 51. Medtronic Revenue in Lung Tumor Ablation Business (US$ Million), 2021–2026
Table 52. Medtronic Recent Development
Table 53. Olympus Company Details
Table 54. Olympus Business Overview
Table 55. Olympus Lung Tumor Ablation Product
Table 56. Olympus Revenue in Lung Tumor Ablation Business (US$ Million), 2021–2026
Table 57. Olympus Recent Development
Table 58. LungCare Company Details
Table 59. LungCare Business Overview
Table 60. LungCare Lung Tumor Ablation Product
Table 61. LungCare Revenue in Lung Tumor Ablation Business (US$ Million), 2021–2026
Table 62. LungCare Recent Development
Table 63. Broncus Company Details
Table 64. Broncus Business Overview
Table 65. Broncus Lung Tumor Ablation Product
Table 66. Broncus Revenue in Lung Tumor Ablation Business (US$ Million), 2021–2026
Table 67. Broncus Recent Development
Table 68. Intuitive Surgica Company Details
Table 69. Intuitive Surgica Business Overview
Table 70. Intuitive Surgica Lung Tumor Ablation Product
Table 71. Intuitive Surgica Revenue in Lung Tumor Ablation Business (US$ Million), 2021–2026
Table 72. Intuitive Surgica Recent Development
Table 73. Auris Health Company Details
Table 74. Auris Health Business Overview
Table 75. Auris Health Lung Tumor Ablation Product
Table 76. Auris Health Revenue in Lung Tumor Ablation Business (US$ Million), 2021–2026
Table 77. Auris Health Recent Development
Table 78. Angiodynamics Company Details
Table 79. Angiodynamics Business Overview
Table 80. Angiodynamics Lung Tumor Ablation Product
Table 81. Angiodynamics Revenue in Lung Tumor Ablation Business (US$ Million), 2021–2026
Table 82. Angiodynamics Recent Development
Table 83. Boston Scientific Company Details
Table 84. Boston Scientific Business Overview
Table 85. Boston Scientific Lung Tumor Ablation Product
Table 86. Boston Scientific Revenue in Lung Tumor Ablation Business (US$ Million), 2021–2026
Table 87. Boston Scientific Recent Development
Table 88. Smith and Nephew Company Details
Table 89. Smith and Nephew Business Overview
Table 90. Smith and Nephew Lung Tumor Ablation Product
Table 91. Smith and Nephew Revenue in Lung Tumor Ablation Business (US$ Million), 2021–2026
Table 92. Smith and Nephew Recent Development
Table 93. VISON Medical Company Details
Table 94. VISON Medical Business Overview
Table 95. VISON Medical Lung Tumor Ablation Product
Table 96. VISON Medical Revenue in Lung Tumor Ablation Business (US$ Million), 2021–2026
Table 97. VISON Medical Recent Development
Table 98. Nanjing MICRO-TECH Company Details
Table 99. Nanjing MICRO-TECH Business Overview
Table 100. Nanjing MICRO-TECH Lung Tumor Ablation Product
Table 101. Nanjing MICRO-TECH Revenue in Lung Tumor Ablation Business (US$ Million), 2021–2026
Table 102. Nanjing MICRO-TECH Recent Development
Table 103. TIPC Company Details
Table 104. TIPC Business Overview
Table 105. TIPC Lung Tumor Ablation Product
Table 106. TIPC Revenue in Lung Tumor Ablation Business (US$ Million), 2021–2026
Table 107. TIPC Recent Development
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
Table 111. Authors List of This Report
List of Figures
Figure 1. Lung Tumor Ablation Picture
Figure 2. Global Lung Tumor Ablation Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Lung Tumor Ablation Market Share by Type: 2025 vs 2032
Figure 4. Radiofrequency Ablation (RFA) Features
Figure 5. Microwave Ablation (MWA) Features
Figure 6. Cold Ablation Features
Figure 7. Others Features
Figure 8. Global Lung Tumor Ablation Market Size by Application (US$ Million), 2021–2032
Figure 9. Global Lung Tumor Ablation Market Share by Application: 2025 vs 2032
Figure 10. Hospitals Case Studies
Figure 11. Ambulatory Surgical Centers Case Studies
Figure 12. Lung Tumor Ablation Report Years Considered
Figure 13. Global Lung Tumor Ablation Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 14. Global Lung Tumor Ablation Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 15. Global Lung Tumor Ablation Market Share by Region: 2025 vs 2032
Figure 16. Global Lung Tumor Ablation Market Share by Players in 2025
Figure 17. Global Lung Tumor Ablation Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 18. The Top 10 and 5 Players Market Share by Lung Tumor Ablation Revenue in 2025
Figure 19. North America Lung Tumor Ablation Market Size YoY Growth (US$ Million), 2021–2032
Figure 20. North America Lung Tumor Ablation Market Share by Country (2021–2032)
Figure 21. United States Lung Tumor Ablation Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. Canada Lung Tumor Ablation Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Europe Lung Tumor Ablation Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Europe Lung Tumor Ablation Market Share by Country (2021–2032)
Figure 25. Germany Lung Tumor Ablation Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. France Lung Tumor Ablation Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. U.K. Lung Tumor Ablation Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Italy Lung Tumor Ablation Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Russia Lung Tumor Ablation Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Ireland Lung Tumor Ablation Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Asia-Pacific Lung Tumor Ablation Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Asia-Pacific Lung Tumor Ablation Market Share by Region (2021–2032)
Figure 33. China Lung Tumor Ablation Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Japan Lung Tumor Ablation Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. South Korea Lung Tumor Ablation Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Southeast Asia Lung Tumor Ablation Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. India Lung Tumor Ablation Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Australia & New Zealand Lung Tumor Ablation Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Latin America Lung Tumor Ablation Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Latin America Lung Tumor Ablation Market Share by Country (2021–2032)
Figure 41. Mexico Lung Tumor Ablation Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Brazil Lung Tumor Ablation Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Middle East & Africa Lung Tumor Ablation Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Middle East & Africa Lung Tumor Ablation Market Share by Country (2021–2032)
Figure 45. Israel Lung Tumor Ablation Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Saudi Arabia Lung Tumor Ablation Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. UAE Lung Tumor Ablation Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. Medtronic Revenue Growth Rate in Lung Tumor Ablation Business (2021–2026)
Figure 49. Olympus Revenue Growth Rate in Lung Tumor Ablation Business (2021–2026)
Figure 50. LungCare Revenue Growth Rate in Lung Tumor Ablation Business (2021–2026)
Figure 51. Broncus Revenue Growth Rate in Lung Tumor Ablation Business (2021–2026)
Figure 52. Intuitive Surgica Revenue Growth Rate in Lung Tumor Ablation Business (2021–2026)
Figure 53. Auris Health Revenue Growth Rate in Lung Tumor Ablation Business (2021–2026)
Figure 54. Angiodynamics Revenue Growth Rate in Lung Tumor Ablation Business (2021–2026)
Figure 55. Boston Scientific Revenue Growth Rate in Lung Tumor Ablation Business (2021–2026)
Figure 56. Smith and Nephew Revenue Growth Rate in Lung Tumor Ablation Business (2021–2026)
Figure 57. VISON Medical Revenue Growth Rate in Lung Tumor Ablation Business (2021–2026)
Figure 58. Nanjing MICRO-TECH Revenue Growth Rate in Lung Tumor Ablation Business (2021–2026)
Figure 59. TIPC Revenue Growth Rate in Lung Tumor Ablation Business (2021–2026)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which region is expected to have the highest market share?
For each regional market, the report conducted in-depth comparative analysis from multiple dimensions such as market size, 9.3% compound annual growth rate, market demand, industrial structure, policy environment, and the layout of major enterprises. It systematically summarized the market characteristics and competitive environment of different regions. At the same time, it also focused on analyzing the demand structure, market growth drivers, and investment environment of each region, providing valuable references for enterprises to identify key regional markets, formulate global market layouts and sales strategies.
What is the annual compound growth rate of the global Lung Tumor Ablation market size from 2026 to 2032?
What was the global market size of Lung Tumor Ablation in 2026?
Which companies rank high in the global Lung Tumor Ablation market?
What was the global market size of Lung Tumor Ablation in 2032?
Related Reports
Lung Tumor Ablation - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Lung Tumor Ablation was estimated to be worth US$ 2425 million in 2025 and is projected to reach US$ 4480 million, growing at a CAGR of 9.3% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 118
USD 3950.00
(Single User License)
Global Lung Tumor Ablation Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Lung Tumor Ablation market size was US$ 2237 million in 2024 and is forecast to a readjusted size of US$ 4134 million by 2031 with a CAGR of 9.3% during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 94
USD 4250.00
(Single User License)
Global Lung Tumor Ablation Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Lung Tumor Ablation market is projected to grow from US$ 2237 million in 2024 to US$ 4134 million by 2031, at a CAGR of 9.3% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-11-02
Pages: 136
USD 4900.00
(Single User License)
Lung Tumor Ablation- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Lung Tumor Ablation was estimated to be worth US$ 2237 million in 2024 and is forecast to a readjusted size of US$ 4134 million by 2031 with a CAGR of 9.3% during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 117
USD 3950.00
(Single User License)
Global Lung Tumor Ablation Market Research Report 2025
The global market for Lung Tumor Ablation was valued at US$ 2237 million in the year 2024 and is projected to reach a revised size of US$ 4134 million by 2031, growing at a CAGR of 9.3% during the forecast period.
Published Date: 2025-01-13
Pages: 90
USD 2900.00
(Single User License)
Global Lung Tumor Ablation Market Insights, Forecast to 2030
Lung tumor ablation is a minimally-invasive image-guided procedure (MIIP) to destroy the cancer without having to cut it out. Ablation can be an effective treatment option for patients who wish to avoid surgery or for whom surgery is not an option.
Published Date: 2024-04-15
Pages: 107
USD 4900.00
(Single User License)
Global Lung Tumor Ablation Market Research Report 2024
Lung tumor ablation is a minimally-invasive image-guided procedure (MIIP) to destroy the cancer without having to cut it out. Ablation can be an effective treatment option for patients who wish to avoid surgery or for whom surgery is not an option.
Published Date: 2024-01-18
Pages: 86
USD 2900.00
(Single User License)
Lung Tumor Ablation - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Lung Tumor Ablation was estimated to be worth US$ 2425 million in 2025 and is projected to reach US$ 4480 million, growing at a CAGR of 9.3% from 2026 to 2032.
Published: 2026-06-16
Pages: 118
USD 3950.00 (Single User License)Global Lung Tumor Ablation Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Lung Tumor Ablation market size was US$ 2237 million in 2024 and is forecast to a readjusted size of US$ 4134 million by 2031 with a CAGR of 9.3% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 94
USD 4250.00 (Single User License)Global Lung Tumor Ablation Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Lung Tumor Ablation market is projected to grow from US$ 2237 million in 2024 to US$ 4134 million by 2031, at a CAGR of 9.3% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-11-02
Pages: 136
USD 4900.00 (Single User License)Lung Tumor Ablation- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Lung Tumor Ablation was estimated to be worth US$ 2237 million in 2024 and is forecast to a readjusted size of US$ 4134 million by 2031 with a CAGR of 9.3% during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 117
USD 3950.00 (Single User License)Global Lung Tumor Ablation Market Research Report 2025
The global market for Lung Tumor Ablation was valued at US$ 2237 million in the year 2024 and is projected to reach a revised size of US$ 4134 million by 2031, growing at a CAGR of 9.3% during the forecast period.
Published: 2025-01-13
Pages: 90
USD 2900.00 (Single User License)Global Lung Tumor Ablation Market Insights, Forecast to 2030
Lung tumor ablation is a minimally-invasive image-guided procedure (MIIP) to destroy the cancer without having to cut it out. Ablation can be an effective treatment option for patients who wish to avoid surgery or for whom surgery is not an option.
Published: 2024-04-15
Pages: 107
USD 4900.00 (Single User License)Global Lung Tumor Ablation Market Research Report 2024
Lung tumor ablation is a minimally-invasive image-guided procedure (MIIP) to destroy the cancer without having to cut it out. Ablation can be an effective treatment option for patients who wish to avoid surgery or for whom surgery is not an option.
Published: 2024-01-18
Pages: 86
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 2900.00
USD 4350.00
USD 5800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now